Who Paid My Doc
Research studies in the Open Payments record
139,921 studies have research funding reported against them. Being named on a study as a principal investigator is reported separately from being paid.
Studies
50 of 139,921- 20-03 No ClinicalTrials.gov identifier reported
- 20-08 No ClinicalTrials.gov identifier reported
- 2008-0431 No ClinicalTrials.gov identifier reported
- 2010-0708 No ClinicalTrials.gov identifier reported
- 2010-0991 No ClinicalTrials.gov identifier reported
- 2010-0991_R No ClinicalTrials.gov identifier reported
- 20103-Shah Consulting Agreement No ClinicalTrials.gov identifier reported
- 201106379 No ClinicalTrials.gov identifier reported
- 2011-0785 NCT01829568
- 2011-0785 No ClinicalTrials.gov identifier reported
- 2013-0090 No ClinicalTrials.gov identifier reported
- 20130295-FOURIER OLE (Ph 4) No ClinicalTrials.gov identifier reported
- 20130295-FOURIER OLE Ph 4 No ClinicalTrials.gov identifier reported
- 2013-0703 No ClinicalTrials.gov identifier reported
- 2013-13 Rose No ClinicalTrials.gov identifier reported
- 2014-0559 NCT02427620
- 2014-0559 No ClinicalTrials.gov identifier reported
- 201411060 No ClinicalTrials.gov identifier reported
- 2014-11 Palefsky No ClinicalTrials.gov identifier reported
- 2014-23 Siegel No ClinicalTrials.gov identifier reported
- 2014-25 Palefsky No ClinicalTrials.gov identifier reported
- 2014-26 Shofler No ClinicalTrials.gov identifier reported
- 201-4898-Gottlieb No ClinicalTrials.gov identifier reported
- 2014-NUL-0029 A Personalized Biomarker Based Feasibility Trial to Convert Renal Transplant Recipients to Belatacept Monotherapy No ClinicalTrials.gov identifier reported
- 2015-0281 No ClinicalTrials.gov identifier reported
- 2015-0860 No ClinicalTrials.gov identifier reported
- 2015-0895 No ClinicalTrials.gov identifier reported
- 2015-0928 No ClinicalTrials.gov identifier reported
- 201510157 No ClinicalTrials.gov identifier reported
- 2015-1038 Den No ClinicalTrials.gov identifier reported
- 2015-1039 Susin No ClinicalTrials.gov identifier reported
- 2015-1048 Bhatia No ClinicalTrials.gov identifier reported
- 2015-1053 Bhatia No ClinicalTrials.gov identifier reported
- 2015-1060 Markowitz No ClinicalTrials.gov identifier reported
- 2015-1060-Markowitz No ClinicalTrials.gov identifier reported
- 2015 Aspire Breast Cancer A Phase 1B 2A Study of Palbociclib in Combination With Everolimus and Exemestane in Postmenopausal Women With Estrogen Receptor Positive and Her2 Negative Metastatic Breast Cancer No ClinicalTrials.gov identifier reported
- 2015 Aspire Breast Cancer A Phase 1B 2A Study of Palbociclib in Combination With Everolimus and Exemestane in Postmenopausal Women With Estrogen Receptor Positive and Her2 Negative Metastatic Breast Cancer No ClinicalTrials.gov identifier reported
- 2015 Aspire Breast Cancer A Single Arm Phase II Study of Palbociclib in Combination With Tamoxifen As First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer No ClinicalTrials.gov identifier reported
- 2015 Aspire Breast Cancer A Single Arm Phase II Study of Palbociclib in Patients With Metastatic Her2positive Or Triple Negative Breast Cancer With Brain Metastasis No ClinicalTrials.gov identifier reported
- 2015 Aspire Breast Cancer A Single Arm Phase II Study of Palbociclib in Patients With Metastatic Her2positive Or Triple Negative Breast Cancer With Brain Metastasis No ClinicalTrials.gov identifier reported
- 2015 Aspire Breast Cancer Phase II Safety Study of Palbociclic in Combination With Letrozole in African American Women With Hormone Receptor Positive Her2 Negative Advanced Breast Cancer No ClinicalTrials.gov identifier reported
- 2015 Aspire Breast Cancer Phase II Trial of Primary Endocrine Therapy With Combination of Fulvestrant and Palbociclib in Elderly Frail Patients With Hormonre Responsive Breast Cancer No ClinicalTrials.gov identifier reported
- 2015 Aspire Breast Cancer Phase II Trial of Primary Endocrine Therapy With Combination of Fulvestrant and Palbociclib in Elderly Frail Patients With Hormonre Responsive Breast Cancer No ClinicalTrials.gov identifier reported
- 2015 Aspire CML Therapeutic Drug Monitoring of Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitor Therapy Using Scalp Hair Concentrations No ClinicalTrials.gov identifier reported
- 2015 Aspire US Rheuma Derma Exploring Biomarkers to Predict the Subtype and Progression of Interstitial Lung Disease in Rheumatoid Arthritis No ClinicalTrials.gov identifier reported
- 2015 Aspire US Rheuma Derma Oral Psoriasis Treatment Adherence and Intervention Study No ClinicalTrials.gov identifier reported
- 2015-NIV-0362 Ph II study of Optimized Management of NIVO based on REsponse in pts with adv renal cell carcinoma OMNIVORE study No ClinicalTrials.gov identifier reported
- 2015-NIV-0383 A phase II study of ipilimumab and nivolumab in patients with advanced Non Small Cell Lung Cancer resistant to nivolumab monotherapy No ClinicalTrials.gov identifier reported
- 2015-NIV-0383 A phase II study of ipilimumab and nivolumab in patients with advanced NSCLC resistant to nivolumab monotherapy No ClinicalTrials.gov identifier reported
- 20160250-FOURIER OLE (Ph 4) No ClinicalTrials.gov identifier reported